Jinender Kumar - Bristol Myers Squibb

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Patient-Reported Outcomes (pros) from the Phase 2 TRANSCEND FL Study of Lisocabtagene Maraleucel (Liso-Cel) in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL)

Gillaume Cartron,Alejandro Martin Garcia-Sancho,Juan Luis Reguera,Saurabh Dahiya,Shien Guo,Ling Shi,Laurie Eliason,Jinender Kumar,Thalia Farazi,Omotayo Fasan,Koji Izutsu

BLOOD (2023)

引用0浏览0引用

A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis

Allie Cichewicz,Tom Tencer,Komal Gupte-Singh, Sonya Egodage,Heather Burnett,Jinender Kumar

Advances in Therapyno. 5 (2023): 2116-2146

引用0浏览0WOS引用

Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis

Singh H, Wilson L,Tencer T,Kumar J

ClinicoEconomics and Outcomes Research（2023）

引用1浏览0引用

Matching-Adjusted Indirect Comparison (MAIC) of Efficacy and Safety of Lisocabtagene Maraleucel (Liso-Cel) and Mosunetuzumab for the Treatment (tx) of Third Line or Later (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Loretta J. Nastoupil,Ashley Bonner,Pearl Wang,Lamees Almuallem, Jigar Desai,Omotayo Fasan,Thalia Farazi,Jinender Kumar,Saurabh Dahiya

Bloodno. Supplement 1 (2023): 2338-2338

引用0浏览0引用

Patient-Reported Outcomes from the MCL Cohort of the Phase 1, Seamless Design TRANSCEND NHL 001 Study of Lisocabtagene Maraleucel in Patients with R/R B-Cell NHL

Michael L. Wang,Leo I. Gordon,Alexandre V. Hirayama,Matthew A. Lunning,Ling Shi,Shien Guo,Ana Kostic,Laurie Eliason,Jinender Kumar,Maria Lia Palomba

Bloodno. Supplement 1 (2023): 667-667

引用0浏览0引用

EP1029: EVALUATION OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN MODERATE-TO-SEVERE ULCERATIVE COLITIS PARTICIPANTS TREATED WITH OZANIMOD IN THE PHASE 3 TRUE NORTH STUDY

Libby Floden,Tan Phat Pham,Jinender Kumar, Brandon Becker, James W. Shaw,T. Tencer

Gastroenterology（2022）

引用2浏览0引用

P468 Evaluation of Work Productivity and Activity Impairment in Moderate-to-severe Ulcerative Colitis Participants Treated with Ozanimod in the Phase 3 True North Study

Lysbeth Floden, Tram Pham,Jinender Kumar, Brandon Becker, JW Shaw, T. Tencer

Journal of Crohn s and Colitisno. Supplement_1 (2022): i441-i442

引用0浏览0引用

Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes

Anuja Pandey, Lea Achrafie,Petya Kodjamanova,Tom Tencer,Jinender Kumar

CURRENT MEDICAL RESEARCH AND OPINION（2022）

引用1浏览0WOS引用

S17 Treatment Patterns among Moderate-to-Severe Ulcerative Colitis Patients in TARGET-IBD

Benjamin Cohen,Benjamin Click,Edward Barnes,Ryan Ungaro,Komal Gupte-Singh,Jinender Kumar,Garrett Lawlor,James Canavan,Julie Crawford,Breda Munoz,Anthony Perez,Heather Morris,Millie Long,Bruce Sands

The American journal of gastroenterologyno. 1 (2022): S5-S5

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn